Financhill
Back

Nektar Therapeutics Stock Predictions

Nektar Therapeutics Stock Forecast

  • Is Nektar Therapeutics Stock Undervalued?
    The current Nektar Therapeutics [NKTR] share price is $1.46. The Score for NKTR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Nektar Therapeutics Stock Go Up Next Year?

Data Unavailable

Nektar Therapeutics Stock Rating

Data Unavailable

Nektar Therapeutics Stock Price History

Is NKTR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com

52-Week Data

52-Week High:
1.75
52-Week Low:
0.41

Prediction Charts

Market Cap:
268.08M
Price in USD:
1.46
Volume:
808.77K
Beta:
1.16

Technical Analysis

SMA50:
1.05
SMA100:
0.81
SMA200:
0.70
52-Wk Change:
94.07%

Stock Predictions

  • Is Nektar Therapeutics stock public?
    Yes, Nektar Therapeutics is a publicly traded company.
  • What is the Nektar Therapeutics stock quote today?
    The Nektar Therapeutics stock price is 1.46 USD today.
  • How to buy Nektar Therapeutics stock online?
    You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-11 1.40 1.58 1.75 1.36
Apr-12 1.58 1.67 1.68 1.48
Apr-15 1.68 1.57 1.70 1.50
Apr-16 1.47 1.49 1.58 1.45
Apr-17 1.48 1.35 1.50 1.28
Apr-18 1.32 1.32 1.36 1.27
Apr-19 1.33 1.26 1.33 1.20
Apr-22 1.31 1.36 1.41 1.29
Apr-23 1.39 1.42 1.43 1.31
Apr-24 1.37 1.38 1.42 1.37
Apr-25 1.36 1.32 1.37 1.29
Apr-26 1.33 1.32 1.38 1.31
Apr-29 1.35 1.46 1.53 1.35
Apr-30 1.45 1.46 1.52 1.40

Nektar Therapeutics Earnings

Data Unavailable

Nektar Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.06 per share.

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.